You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
6 October 2026 - Defence and space technology company Voyager Technologies (NYSE:VOYG) said on Tuesday that it has signed a contract with the Center for the Advancement of Science in Space to manage Symphony Biosciences' cancer research experime...
6 October 2026 - Mozart Therapeutics Inc, a developer of CD8 Treg network modulators for the treatment of autoimmune disease, announced on Monday the presentation of clinical and preclinical data for its lead development programme, MTX-101, at the 62...
5 October 2026 - Biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) said on Monday that it has completed a USD2bn strategic equity investment in biopharmaceutical oncology company Summit Therapeutics Inc (NASDAQ:SMMT) to support...
5 October 2026 - Medical technology company GE HealthCare (Nasdaq:GEHC) announced on Monday that it has agreed to acquire SOFIE Biosciences from Trilantic North America for USD945m in cash, expanding its US radiopharmaceutical manufacturing footprint...
5 October 2026 - Australian biopharma company CSL Limited (ASX:CSL) (USOTC:CSLLY) and Swiss biotechnology company Alentis Therapeutics announced on Sunday that they have entered into an exclusive global collaboration agreement to co-develop and co-pr...
5 October 2026 - Aroa Biosurgery Limited (ASX:ARX), a New Zealand-based soft tissue regeneration company, on Monday reported positive results from a prospective, multicentre randomised controlled trial (RCT) of Symphony, published in the Internationa...
Johnson & Johnson reports two-year ICOTYDE data showing sustained clearance in high-impact psoriasis
2 October 2026 - US healthcare company Johnson & Johnson (NYSE: JNJ) on Friday announced the release of two-year Phase 3 results from ICONIC-TOTAL assessing ICOTYDE (icotrokinra) in adults and adolescents with moderate high-impact plaque psoriasi...